Pharmaceutical Powerhouse Chooses Esco for Forefront Laboratory Solutions
In a strategic move to enhance its capabilities and ensure the highest standards in research and development, a leading and rapidly growing pharmaceutical company has selected Esco, a renowned global provider of laboratory equipment, for various critical units within its facilities. The collaboration spans across Quality Control, Microbiology, Research and Development, Oncology Laboratory, Cephalosporin Unit, and Potent Product Facility.
Investing in Cutting-Edge Equipment:
The pharmaceutical giant has made a significant investment in state-of-the-art equipment to bolster its operations and maintain a robust research and development infrastructure. The following units have been purchased as part of this collaboration:
-
Cytotoxic Safety Cabinet (CYT): A total of nine units have been acquired, including five 6ft CYTs and four 4ft CYT. These cabinets are designed to provide a secure environment for the handling of cytotoxic substances, ensuring the safety of researchers and the integrity of the pharmaceutical products.
-
Biological Safety Cabinet (BSC): Three 6ft BSCs were installed. These cabinets are crucial for maintaining aseptic conditions during experiments involving biological materials, contributing to the precision and reliability of the pharmaceutical company's research.
-
Ducted Fume Hood (FH): The company has invested in seven ducted fume hoods, including four 6ft FHs and three 4ft FHs. These hoods play a pivotal role in ensuring the safety of laboratory personnel by efficiently removing harmful fumes and maintaining a clean working environment.
-
Ductless Fume Hood: One unit of a ductless fume hood has been incorporated into the laboratory infrastructure, offering flexibility in laboratory setup while maintaining high levels of safety and containment.
-
Ventilated Balance Enclosure: Three units of ventilated balance enclosures have been added to the facility. These enclosures provide controlled environments for weighing and handling sensitive substances, enhancing the accuracy and reliability of the pharmaceutical company's research processes.
-
Polymerase Chain Reaction (PCR) Cabinet: Two units of 4ft PCR cabinets have been acquired. These cabinets are designed to provide a contamination-free environment for conducting PCR experiments, crucial for the development of advanced pharmaceutical products.
-
Centrifuge: A single unit of a centrifuge has been added to the equipment portfolio, facilitating the separation of substances based on density and contributing to various laboratory processes.
-
Anti-vibration Plate: To ensure the precision and accuracy of delicate laboratory instruments, the pharmaceutical company has acquired an anti-vibration plate.
The Road Ahead:
This strategic partnership with Esco Lifesciences marks a significant step forward for the pharmaceutical company, reinforcing its commitment to excellence in research, development, and quality control.
The various laboratory equipment from Esco is poised to play a crucial role in accelerating innovation, ensuring product safety, and contributing to the pharmaceutical industry's growth. As the company continues to expand its footprint in the global market, this investment in advanced laboratory solutions reaffirms its position as a leader in the pharmaceutical landscape.
Want to upgrade your laboratory setup? Ask us how!
Contact Us:
Esco Lifesciences (Bangladesh) Pvt. Ltd
House No. 662 Road No. 9 ,Apt No A-6 (6th Floor)
Mirpur DOHS, Dhaka-1216, Bangladesh
+8801958-541100
rafia.oshin@escolifesciences.com